COVID-19 cases are now plateauing across most of the United States, but with new variants of the virus out there, vaccine makers are scrambling to make sure those who get the shots remain protected.
COVID-19 cases are now plateauing across most of the United States, but with new variants of the virus out there, vaccine makers are scrambling to make sure those who get the shots remain protected.
Johnson & Johnson announced Friday that its single-dose vaccine was 66% effective globally in preventing COVID-19, and 72%..
Coronavirus cases have been on the rise but there is a glimmer of hope with cases, slowly starting to decline.